The Artificial Kidney Prize builds on past KidneyX competitions but is distinct in its goal: to accelerate the development of continuous kidney replacement therapies that provide transformational treatment options beyond current dialysis methods.
For this competition, artificial kidneys may be wearable, implantable, bioengineered, developed as a xenotransplant or chimera organ, or other approaches not yet conceived. The competition aims to bring these artificial kidney solutions toward human clinical trials with a greater level of maturity, functionality, and potential for patient impact than is currently possible. With the Artificial Kidney Prize, HHS and ASN intend to stimulate the market for further kidney health innovation, drawing greater participation and capital. Additionally, through fostering a collaborative solver community, the competition will support the development of cross-disciplinary solutions necessary for success.
The competition will award up to $10 million. Up to $4 million in Phase 1 prizes will be distributed among up to eight Phase 1 winners, at the discretion of HHS and ASN. For Phase 2, up to $6 million in prizes will be distributed to winners at the discretion of HHS and ASN. Up to $2.5 million in prizes will be awarded by HHS over Phases 1-2; up to $7.5 million in prizes will be awarded by ASN over Phases 1-2. (See the official rules, terms, and conditions for further details.)